Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$220.94
-0.27-0.12%
Última actualización: Nov 17, 2:32 PM
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Danaher Corp tiene un precio objetivo de consenso de $258.84 basado en las calificaciones de 26 analistas. El máximo es $315, emitido por Stephens & Co. el octubre 23, 2024. El mínimo es $220, emitido por Rothschild & Co el octubre 8, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Wells Fargo, TD Cowen y Barclays el octubre 23, 2025, octubre 22, 2025 y octubre 22, 2025, respectivamente. Con un precio objetivo promedio de $246.67 entre Wells Fargo, TD Cowen y Barclays, hay una 11.64% upside implícita para Danaher Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
TD Cowen
Barclays
Rothschild & Co
Evercore ISI Group
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Danaher
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/23/2025 | 4.1% | Wells Fargo | $205 → $230 | Maintains | Equal-Weight | |||
10/22/2025 | 17.68% | TD Cowen | $250 → $260 | Maintains | Buy | |||
10/22/2025 | 13.15% | Barclays | $225 → $250 | Maintains | Overweight | |||
10/08/2025 | -0.43% | Rothschild & Co | $245 → $220 | Downgrade | Buy → Neutral | |||
10/07/2025 | 10.89% | Evercore ISI Group | $226 → $245 | Maintains | Outperform | |||
09/22/2025 | -0.43% | B of A Securities | $230 → $220 | Maintains | Buy | |||
07/23/2025 | 1.84% | UBS | $240 → $225 | Maintains | Buy | |||
07/23/2025 | -7.21% | Wells Fargo | $210 → $205 | Maintains | Equal-Weight | |||
07/23/2025 | 13.15% | Guggenheim | $250 → $250 | Reiterates | Buy → Buy | |||
07/23/2025 | 3.65% | Baird | $226 → $229 | Maintains | Outperform | |||
07/18/2025 | 2.29% | Baird | $225 → $226 | Maintains | Outperform | |||
07/11/2025 | 24.47% | Scotiabank | → $275 | Upgrade | Sector Perform → Sector Outperform | |||
07/08/2025 | 2.29% | Evercore ISI Group | $230 → $226 | Maintains | Outperform | |||
06/24/2025 | 1.84% | Barclays | $215 → $225 | Maintains | Overweight | |||
04/23/2025 | 13.15% | RBC Capital | $250 → $250 | Reiterates | Outperform → Outperform | |||
04/23/2025 | 8.63% | Goldman Sachs | $260 → $240 | Maintains | Buy | |||
04/23/2025 | 13.15% | Guggenheim | $250 → $250 | Reiterates | Buy → Buy | |||
04/23/2025 | 8.63% | UBS | $275 → $240 | Maintains | Buy | |||
04/23/2025 | 1.84% | Baird | $231 → $225 | Maintains | Outperform | |||
04/22/2025 | -2.69% | Barclays | $205 → $215 | Maintains | Overweight | |||
04/22/2025 | 17.68% | JP Morgan | $280 → $260 | Maintains | Overweight | |||
04/22/2025 | 4.1% | Jefferies | $260 → $230 | Maintains | Buy | |||
04/16/2025 | 4.55% | Baird | $258 → $231 | Maintains | Outperform | |||
04/10/2025 | -7.21% | Barclays | $240 → $205 | Upgrade | Equal-Weight → Overweight | |||
03/14/2025 | 17.68% | Stifel | → $260 | Upgrade | Hold → Buy | |||
02/03/2025 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
01/30/2025 | 19.94% | Citigroup | $285 → $265 | Maintains | Buy | |||
01/30/2025 | 25.37% | RBC Capital | $299 → $277 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 16.77% | Baird | $268 → $258 | Maintains | Outperform | |||
01/30/2025 | 8.63% | Wells Fargo | $280 → $240 | Maintains | Equal-Weight | |||
01/30/2025 | 8.63% | Barclays | $275 → $240 | Maintains | Equal-Weight | |||
01/29/2025 | 17.68% | Jefferies | $285 → $260 | Maintains | Buy | |||
01/21/2025 | 24.47% | Raymond James | $300 → $275 | Maintains | Outperform | |||
01/06/2025 | 28.99% | Citigroup | $305 → $285 | Maintains | Buy | |||
12/23/2024 | 19.94% | Scotiabank | → $265 | Initiates | → Sector Perform | |||
12/13/2024 | 31.26% | B of A Securities | $290 → $290 | Upgrade | Neutral → Buy | |||
10/31/2024 | 28.99% | Wolfe Research | → $285 | Upgrade | Peer Perform → Outperform | |||
10/23/2024 | 40.76% | RBC Capital | $333 → $311 | Maintains | Outperform | |||
10/23/2024 | 42.57% | TD Cowen | $310 → $315 | Maintains | Buy | |||
10/23/2024 | 40.31% | Keybanc | $290 → $310 | Maintains | Overweight | |||
10/23/2024 | 42.57% | Stephens & Co. | $315 → $315 | Reiterates | Overweight → Overweight | |||
10/23/2024 | 19.94% | Stifel | $250 → $265 | Maintains | Hold | |||
10/23/2024 | 38.05% | UBS | $309 → $305 | Maintains | Buy | |||
10/23/2024 | 35.78% | Raymond James | $310 → $300 | Maintains | Outperform | |||
10/23/2024 | 24.47% | Barclays | $285 → $275 | Maintains | Equal-Weight | |||
10/23/2024 | 25.37% | Baird | $278 → $277 | Maintains | Outperform | |||
10/01/2024 | 25.83% | Evercore ISI Group | $275 → $278 | Maintains | Outperform | |||
10/01/2024 | 42.57% | Stephens & Co. | → $315 | Initiates | → Overweight | |||
09/06/2024 | 35.78% | RBC Capital | $300 → $300 | Reiterates | Outperform → Outperform | |||
08/27/2024 | 26.73% | Wells Fargo | → $280 | Initiates | → Equal-Weight | |||
07/24/2024 | 25.83% | Baird | $271 → $278 | Maintains | Outperform | |||
07/24/2024 | 35.78% | RBC Capital | $297 → $300 | Maintains | Outperform | |||
07/24/2024 | 28.99% | Barclays | $270 → $285 | Maintains | Equal-Weight | |||
07/24/2024 | 26.73% | Leerink Partners | — | $275 → $280 | Maintains | Outperform | ||
07/24/2024 | 13.15% | Stifel | $235 → $250 | Maintains | Hold | |||
07/24/2024 | 13.15% | Goldman Sachs | $225 → $250 | Maintains | Neutral | |||
07/24/2024 | 40.31% | TD Cowen | $290 → $310 | Maintains | Buy | |||
07/24/2024 | 24.47% | B of A Securities | $270 → $275 | Maintains | Neutral | |||
07/02/2024 | 17.68% | Evercore ISI Group | $266 → $260 | Maintains | Outperform | |||
04/24/2024 | 31.26% | Citigroup | $280 → $290 | Maintains | Buy | |||
04/24/2024 | 31.26% | TD Cowen | $280 → $290 | Maintains | Buy | |||
04/24/2024 | 22.21% | B of A Securities | $258 → $270 | Maintains | Neutral | |||
04/24/2024 | 22.21% | Barclays | $260 → $270 | Maintains | Equal-Weight | |||
04/24/2024 | 22.66% | Baird | $259 → $271 | Maintains | Outperform | |||
04/17/2024 | 26.73% | HSBC | $250 → $280 | Upgrade | Hold → Buy | |||
04/10/2024 | 17.68% | Barclays | $240 → $260 | Maintains | Equal-Weight | |||
04/08/2024 | 13.15% | RBC Capital | $270 → $250 | Maintains | Outperform | |||
02/01/2024 | 31.26% | Keybanc | $260 → $290 | Maintains | Overweight | |||
01/31/2024 | 22.21% | Raymond James | $240 → $270 | Maintains | Outperform | |||
01/31/2024 | 27.64% | RBC Capital | $254 → $282 | Maintains | Outperform | |||
01/31/2024 | 26.73% | Citigroup | $255 → $280 | Maintains | Buy | |||
01/24/2024 | 8.63% | Barclays | → $240 | Downgrade | Overweight → Equal-Weight | |||
12/20/2023 | 22.21% | JP Morgan | $250 → $270 | Maintains | Overweight | |||
12/18/2023 | — | HSBC | — | Initiates | → Hold | |||
12/13/2023 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
12/11/2023 | 15.42% | Citigroup | $240 → $255 | Maintains | Buy | |||
12/07/2023 | -7.21% | Goldman Sachs | $215 → $205 | Downgrade | Buy → Neutral | |||
10/26/2023 | -2.69% | Goldman Sachs | $250 → $215 | Maintains | Buy | |||
10/26/2023 | -2.69% | Barclays | $290 → $215 | Maintains | Overweight | |||
10/25/2023 | 13.15% | JP Morgan | $260 → $250 | Maintains | Overweight | |||
10/25/2023 | 8.17% | RBC Capital | $246 → $239 | Maintains | Outperform | |||
10/25/2023 | 8.63% | Raymond James | $250 → $240 | Maintains | Outperform | |||
10/25/2023 | 8.63% | Citigroup | $265.92 → $240 | Maintains | Buy | |||
10/25/2023 | 17.68% | Keybanc | $300 → $260 | Maintains | Overweight | |||
10/18/2023 | 13.15% | Raymond James | $290 → $250 | Maintains | Outperform | |||
10/17/2023 | 17.68% | JP Morgan | $300 → $260 | Maintains | Overweight | |||
10/03/2023 | 11.8% | Wells Fargo | $285 → $247 | Maintains | Overweight | |||
09/27/2023 | 35.78% | Keybanc | $325 → $300 | Maintains | Overweight | |||
07/26/2023 | 8.63% | Stifel | $250 → $240 | Maintains | Hold | |||
07/26/2023 | 32.16% | RBC Capital | $260 → $292 | Maintains | Outperform | |||
07/26/2023 | 31.26% | Raymond James | $270 → $290 | Maintains | Outperform | |||
07/26/2023 | 31.26% | Barclays | $260 → $290 | Maintains | Overweight | |||
07/19/2023 | 22.21% | Raymond James | → $270 | Initiates | → Outperform | |||
05/01/2023 | 35.78% | SVB Leerink | → $300 | Initiates | → Outperform | |||
04/27/2023 | 24.47% | Deutsche Bank | $310 → $275 | Maintains | Buy | |||
04/26/2023 | 31.26% | TD Cowen | $320 → $290 | Maintains | Outperform | |||
04/26/2023 | 35.78% | Citigroup | $325 → $300 | Maintains | Buy | |||
04/26/2023 | 13.15% | Stifel | $270 → $250 | Maintains | Hold | |||
04/26/2023 | 17.68% | RBC Capital | $289 → $260 | Maintains | Outperform | |||
04/26/2023 | 17.68% | Goldman Sachs | $300 → $260 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Danaher (DHR)?
El último precio objetivo de Danaher (NYSE:DHR) fue comunicado por Wells Fargo el octubre 23, 2025. La firma de analistas fijó un precio objetivo para $230.00 que espera DHR a rise dentro de 12 meses (un posible 4.10% upside). 36 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Danaher (DHR)?
La última calificación de analistas para Danaher (NYSE:DHR) fue proporcionada por Wells Fargo, y Danaher mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Danaher (DHR)?
La última revisión al alza de Danaher Corp se produjo en julio 11, 2025, cuando Scotiabank elevó su precio objetivo a $275. Scotiabank anteriormente tenía a sector perform para Danaher Corp.
¿Cuándo fue la última revisión a la baja de Danaher (DHR)?
La última revisión a la baja de Danaher Corp se produjo en octubre 8, 2025, cuando Rothschild & Co cambió su precio objetivo de $245 a $220 para Danaher Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Danaher (DHR)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Danaher, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Danaher se registró el octubre 23, 2025, por lo que la próxima calificación estará disponible en torno al octubre 23, 2026.
¿Es correcta la calificación de los analistas sobre Danaher (DHR)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Danaher (DHR) fue un mantuvo con un precio objetivo de $205.00 a $230.00. El precio actual al que cotiza Danaher (DHR) es de $220.94, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.